2755. Activity of Aztreonam-avibactam and Carbapenem-resistant Enterobacterales (CRE) Isolates Collected in a Six-year Period (2017–2022)

BACKGROUND: Beta-lactam/beta-lactamase inhibitor (BL/BLI) combinations and cefiderocol (FDC) have been recommended for the treatment of carbapenem-resistant Enterobacterales (CRE), but extensive comparisons of these agents are limited. We tested the activity of aztreonam-avibactam (ATM-AVI), ceftazi...

Descripción completa

Detalles Bibliográficos
Autores principales: Castanheira, Mariana, Maher, Joshua, Simpson, Katie, Hubler, Cory, Sader, Helio S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678863/
http://dx.doi.org/10.1093/ofid/ofad500.2366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678863/
http://dx.doi.org/10.1093/ofid/ofad500.2366

Ejemplares similares